TY  - GEN
AU  - Hsieh,Hsiao-Yen
AU  - Shen,Cheng-Huang
AU  - Lin,Ru-Inn
AU  - Feng,Yu-Min
AU  - Huang,Shih-Yuan
AU  - Wang,Yuan-Hung
AU  - Wu,Shu-Fen
AU  - Hsu,Cheng-Da
AU  - Chan,Michael W Y
TI  - Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways
SN  - 1872-7980
PY  - 2016///0427
KW  - Angiopoietin-Like Protein 4
KW  - Angiopoietins
KW  - genetics
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cyproheptadine
KW  - G1 Phase Cell Cycle Checkpoints
KW  - Glycogen Synthase Kinase 3
KW  - antagonists & inhibitors
KW  - Glycogen Synthase Kinase 3 beta
KW  - Humans
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Receptors, Serotonin
KW  - analysis
KW  - Signal Transduction
KW  - TOR Serine-Threonine Kinases
KW  - Tuberous Sclerosis Complex 2 Protein
KW  - Tumor Suppressor Proteins
KW  - physiology
KW  - Urinary Bladder Neoplasms
KW  - drug therapy
KW  - beta Catenin
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2015.09.018
ER  -